Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Pharmaceutical preparations company · E9 · FY ends Dec · -$84M FCF
$0.06
$0.00 (-0.83%)
EOD Sep 18, 2026
Negative free cash flow of -$101M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue
N/A
Net Income (TTM)
-$88M
▲ +43.8% YoY
Op. Margin
—
ROIC
-35.86%
▲ +5.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$84M
▲ +38.7% YoY
Op. Cash Flow (TTM)
-$84M
▲ +39.5% YoY
Net Debt
-$249M
Net Cash Position
Cash & Equiv.
$252M
Continue Research
SourceComputed from the 10-Q filed 13 Nov 2023, covering the period ending 30 Sept 2023, as reported to the SEC. Data last refreshed 2 Apr 2026. How this is calculated.
Price from market data, last close as of 18 Sept 2026. Fiscal year ends Dec. Sector medians are approximate S&P 500 benchmarks and update periodically.